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Abstract
Background: Burden of disease estimates are an important resource in public health. Currently, robust estimates
are not available for the burn population. Our objectives are to adapt a refined methodology (INTEGRIS method) to
burns and to apply this new INTEGRIS-burns method to estimate, and compare, the burden of disease of burn
injuries in Australia, New Zealand and the Netherlands.
Methods: Existing European and Western-Australian health-related quality of life (HRQL) datasets were combined to
derive disability weights for three homogenous burn injury groups based on percentage total body surface area
(%TBSA) burned. Subsequently, incidence data from Australia, New Zealand, and the Netherlands from 2010 to 2017
were used to compute annual non-fatal burden of disease estimates for each of these three countries. Non-fatal
burden of disease was measured by years lived with disability (YLD).
Results: The combined dataset included 7159 HRQL (EQ-5D-3 L) outcomes from 3401 patients. Disability weights
ranged from 0.046 (subgroup < 5% TBSA burned > 24 months post-burn) to 0.497 (subgroup > 20% TBSA burned
0–1 months post-burn). In 2017 the non-fatal burden of disease of burns for the three countries (YLDs/100,000
inhabitants) was 281 for Australia, 279 for New Zealand and 133 for the Netherlands.
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Conclusions: This project established a method for more precise estimates of the YLDs of burns, as it is the only
method adapted to the nature of burn injuries and their recovery. Compared to previous used methods, the
INTEGRIS-burns method includes improved disability weights based on severity categorization of burn patients; a
better substantiated proportion of patients with lifelong disability based; and, the application of burn specific
recovery timeframes. Information derived from the adapted method can be used as input for health decision
making at both the national and international level. Future studies should investigate whether the application is
valid in low- and middle- income countries.
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Background
A well-established concept that assesses the impact of
a health problem or disease on a population is bur-
den of disease. Since the Global Financial Crisis,
funding for health care is scrutinised carefully and in-
creasingly objective justification is required for spend-
ing within contemporary political systems. Priority
setting in health care, surveillance, interventions and
resource allocation is based increasingly on burden of
disease and injury studies. Burden of disease com-
prises all health consequences of a disease or injury
in one metric: the disability adjusted life year (DALY),
which allows comparison across diseases and injuries,
populations, and over time [1–3]. This metric com-
bines information regarding loss of health due to pre-
mature mortality with information on non-fatal
disabling effect of diseases and/or injuries in one sin-
gle figure [4–6]. Premature mortality is expressed as
years of life lost (YLLs) and non-fatal health loss as
years lived with disability (YLDs), which are adjusted
for the severity of the disability [7, 8]. YLDs for a
given disease or injury are derived by multiplying the
incidence of the disease or injury by a disability
weight. A disability weight reflects the magnitude of
health loss and has a value between zero and one,
with zero for perfect health and one for a health state
that is equivalent to death [1, 9]. Combining informa-
tion regarding the duration of the disability with the
disease or injury specific disability weights is neces-
sary to derive adequate YLDs and consequently
DALYs [10].
Due to a great variety of outcomes after a single
type of injury, which may vary between mild to very
serious sequelae [10], there was a mismatch between
injury incidence data and disability weights [11]. To
overcome this problem, a refined method, the
INTEGRIS method, to assess the non-fatal burden of
injury was developed by Haagsma et al. [10]. This
method improved the linkage between injury inci-
dence data and injury disability weights by taking into
account the heterogeneity among nature-of-injury
groups. Important adaptations in this novel method
are: 1) a more detailed classification of injuries to ob-
tain more homogenous severity categories, 2) an ex-
tension of the number of short and long-term
disability weights for consequences of injuries, and 3)
assessment of the proportion of patients with a per-
manent disability based on empirical population data
instead of expert opinion [10]. The method consists
of three steps: 1) data collection on the incidence and
age distribution of the studied injury; 2) breaking
down incidence data into homogenous injury categor-
ies at functional level; 3) combination of the grouped
incidence data with disability weights the estimated
duration of the disability [10].
Although a vast improvement over previous
methods, application of this refined method in the
field of burn injury is still difficult as there is no
granular classification of severity of burn injuries to
obtain homogenous burn injury groups. Burns are a
major cause of mortality and morbidity worldwide. As
estimated by the World Health Organization (WHO),
annually, nearly 11 million people worldwide need
medical attention because of a burn injury and burns
cause about 180,000 deaths [12]. Non-fatal burns are
considered a leading cause of morbidity [12]. Many
burn patients experience functional limitations shortly
after burns [13]. Up to 24 months post-burn, most
limitations improve, however, some remain highly
prevalent in a subset of patients in the long-term, like
psychological functioning [13]. Moreover, there are
apparent latent limitations, like participation restric-
tions due to mental well-being, which tend to develop
after physical symptoms subside [13–15]. In the
recent Global Burden of Disease (GBD) study the
burden associated with burn injuries has been
included [16]. YLDs for 2017 presented by the GBD
for burns were 78, 137 and 165 per 100,000 for the
Netherlands, Australia and New Zealand respectively
[16]. However, burn injuries are distinguished into six
heterogeneous groupings, mainly based on burn size,
body region involved and whether or not patients
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received treatment. These categories are hard to apply
as a lot of detailed information is needed to form
these groups [1].
Since the burden of disease is an important input for
health decision-making, planning processes, and priority
setting in health care [17, 18], there is an urgent need to
improve the understanding of the burden due to burn
injury. Thus, the first aim of our study was to adapt the
refined INTEGRIS method of Haagsma et al. [10] to
burn injuries (INTEGRIS-burns), including 1) generating
homogenous groups of burn patients with similar health
consequences, 2) deriving disability weights for these
homogenous burn injury groups, and 3) empirically
assessing the proportion of burn patients with a perman-
ent disability. Our second aim was to apply this adapted
INTEGRIS-burns method to calculate the non-fatal bur-
den of disease of burns for Australia, New Zealand and
the Netherlands.
Methods
This study was conducted in two parts. Firstly, data were
pooled and categorized to establish contemporary
disability weights for burn injury (steps 1–3 below).
Secondly, these disability weights were applied to esti-
mate and compare the burden of disease of burn injury
in three different countries (step 4).
Data sources
Two different datasets were combined to form the
dataset for the present study. The first dataset con-
sisted of health-related quality of life (HRQL) data
from 10 different European studies on HRQL in burn
patients [19]. This dataset was created for an earlier
study in which authors of European studies on HRQL
studies were asked to provide their data to study the
recovery of HRQL of burn patients [19]. The authors
provided consent to use this dataset for the present
study. This dataset includes a wide variety of burn
patients (n = 1649) and time points on which HRQL
was assessed, but relatively few outcomes were
measured shortly (≤1 month) after burn (Table 1).
Further, the European data probably include propor-
tionally more patients with complaints as it was pre-
sumed that burn patients experiencing complaints
were more willing to participate in the studies (par-
ticipation bias). To improve the generalizability of our
results, we included a second dataset from Western
Australia. These data were included from systematic-
ally recorded outcomes from all inpatients (n = 1752)
admitted to the burn center which provided a similar
model of care in terms of access to critical care and
acute surgical interventions. HRQL outcomes of pa-
tients were assessed at all planned follow-up visits in-
cluding four to six weeks; three months; six months;
12 months; and, 24 months scheduled from the date
of burn injury. However, when follow-up was no lon-
ger of benefit, patients were discharged and outcomes
were no longer assessed, or patients self-select and do
not return to ambulatory or video conference (tele-
health) follow up. As a consequence, most outcomes
were available up to 12 months post-burn and longer-
term outcomes were only available from patients that
return for follow-up visits or provide their survey re-
sponses in lieu of attending in person. Thus, patients
with more extensive burns tended to provide their
long-term outcomes, likely resulting in a greater pro-
portion of patients with complaints or negative seque-
lae in the Western Australia data beyond one year
after burn.
The combined dataset included adult burn patients
(≥18 years old) who were admitted to a burn center.
Data was collected between 1995 and 2019, originated
from Australia, Belgium, Germany, Norway, Sweden
and The Netherlands, and was anonymously shared
(Table 1) [19]. In all data sets, patients with cognitive
impairment were excluded. In all European datasets,
patients with poor language proficiency were excluded
as well. All datasets were collected in accordance with
the Declaration of Helsinki and written informed con-
sent was obtained from all individual participants in-
cluded in the study. This study was approved by the
South Metropolitan Health Service Ethics Committee
(registration number RGS2233-SP1). This data is
accessed and analysed with a waiver of consent based
on the proviso of presentation of summarised or ag-
gregated data.
Health-related quality of life measures
It has been recommended that case-based disability
weights (i.e. based on self-reported patient data)
should be used to more accurately quantify the bur-
den of injuries [11]. Patient-reported outcome mea-
sures, such as the EuroQol - 5 Dimensions (EQ-5D),
can be used to obtain such case-based disability
weights [9]. In the data sets included, the EQ-5D
(both the 3 L and 5 L versions) as well as the Medical
Outcome Study Short Form - 36 items (SF-36) were
used to assess patient-reported outcomes (Table 1).
The SF-36 data was transformed into EQ-5D-3 L data
by application of the algorithm developed by Gray
et al. [29], and EQ-5D-5 L data was mapped into EQ-
5D-3 L data using the method of Van Hout et al.
[30]. After these transformations, data were merged
into one large combined EQ-5D-3 L dataset that was
used for the analyses of step 1–3.
The EQ-5D-3 L consists of five dimensions (mobil-
ity, self-care, usual activities, pain/discomfort and
anxiety/depression) and a visual analogue scale
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(VAS) for general health. The five dimensions are
scored on three levels of severity (no problems, some
problems and severe problems) to describe a pa-
tient’s health state [31, 32]. These health states were
converted into utility weights by use of the value set
of the general population of the United Kingdom
(UK) [33]. Utility weights can range between 0
(death) and 1 (full health). It can also have a nega-
tive value (minimum − 0.59) for health states worse
than death. The UK value set was used as not all in-
cluded countries had an own country-specific set
[34]. For the calculation of the empirically derived
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EQ-5D-3 L disability weights, the age and sex ad-
justed health index of the general population of the
United Kingdom was used [35].
Step 1: homogenous severity categorization of burn
patients
To determine groups of burn patients that are homoge-
neous in terms of health consequences, it was necessary
to link incidence data and disability information as the
consequences of burns can vary widely according to se-
verity of the injury [36, 37]. Literature was studied,
short- and long-term EQ-5D data from the combined
dataset was assessed and experts (both clinicians and pa-
tients) were consulted to derive homogenous groups of
burn patients with similar functional outcomes. Precon-
ditions were that 1) these groups are easily identified
within the total group of burn patients and 2) are based
on data that are registered worldwide, so that the group-
ing can be widely applied among burn researchers. Based
on the above described steps and with the assumption
that patients are treated in a similar way and comparable
resources, the next homogenous groups have been
chosen that were comparable on EQ-5D-3 L outcomes:
< 5% TBSA burned (or %TBSA missing), 5–20% TBSA
burned and > 20% TBSA burned. The most severe group
(i.e. > 20%TBSA) is in line with the criteria of the Ameri-
can Burn Association [38].
Step 2: calculation of disability weights
The disability weight is the difference between the
EQ-5D-3 L utility score and the corresponding sex-
and age-specific norm score [10, 39]. Disability
weights for the homogenous groups based on %TBSA
were created by aggregating the disability weights of
the individual patients. Disability weights were calcu-
lated separately for five different time periods in the
recovery of burns, including four time periods in the
short-term (0–1 months, > 1–6 months, > 6–12
months, > 12–24 months) and one in the long-term
(> 24 months) [10]. We also calculated them separ-
ately for the European and Western Australian data
in order to see whether these disability weights
differed.
Step 3: lifelong disability
The proportions of patients with lifelong disability
(i.e. long-term; > 24 months) were determined for each
homogenous group based on EQ-5D-3 L data explor-
ation in the combined dataset and was validated by
expert opinion (both clinicians and patients). Lifelong
disability was assumed when a patient reported a se-
vere problem (level 3 EQ-5D-3 L) in any of the five
EQ-5D-3 L dimensions or mild problems (level 2 EQ-
5D-3 L) for both the dimensions pain/discomfort and
anxiety/depression at two-year follow-up. These two
dimensions were chosen based on literature; these di-
mensions are most often affected by burns [13, 15].
The percentage of patients with lifelong disabilities
was assessed from the combined dataset. Seventeen
Dutch patients and seventeen Australian and Dutch
clinicians were asked to provide their opinions about
the percentage of patients with lifelong disability via a
short survey in order to externally validate the dataset
results. Thirteen patients and fourteen clinicians com-
pleted the survey. The mean percentages reported by
the experts were compared with the percentages re-
vealed by exploring our dataset (Appendix 1). The
percentages revealed by exploring our dataset were
used in the present study. These were: 20% for the
patient group ≤5% TBSA burned, 25% for the group
5–20% TBSA burned and 39% for the group > 20%
TBSA burned.
Step 4: calculation of non-fatal burden of disease of
burns
In order to calculate the non-fatal burden of disease of
burns, incidence data is required. By combining the
disability weights with incidence data, the non-fatal
burden of disease expressed as years lived with disabil-
ity (YLD) was calculated separately for the short-term
(0–1 months, > 1–6 months, > 6–12 months, > 12–24
months) and the long-term (> 24 months), see Fig. 1
and Appendix 2. YLDs were calculated by applying the
following formula:
YLD ¼ number of incident cases
disability weightaverage duration in yearsð Þ
We have contacted several international experts to
find country-level burn incidence data of burn injuries
from multiple countries, including low and middle-
income countries. The only incidence data that was
accessible for use was the data from Australia, New
Zealand and the Netherlands and therefore we used
the data from these three countries to apply the
refined method. Incidence data on burns from
Australia, New Zealand and the Netherlands for the
years 2010 to 2017 were derived from the Burns
Registry of Australia and New Zealand (BRANZ) [40]
and from the Dutch Burn Repository (DBR) R3 [41].
Data from BRANZ included patients that were admit-
ted for at least 24 h to a burn centre or had surgery;
data from the Dutch Burn Repository R3 included pa-
tients admitted for at least two hours to a specialized
burn centre. Due to privacy reasons and potential
identification of patients, BRANZ policy precludes the
provision of exact incidence counts for sub-grouped
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cells between one and five. Therefore, we applied an
assumed incidence rate of 2 as an average for these
categories where specific detail was lacking. The non-
fatal burden of disease was calculated for each of
these three countries separately.
The calculation of YLDs for the short-term (acute
phase) consisted of three steps: (i) gathering data on
the incidence and age and sex distribution of burns,
(ii) breaking down the incidence data into the
homogenous burn categories, and (iii) combining the
grouped incidence data with the relevant disability
weights and durations (i.e. 0–1 month, > 1–6 months,
> 6–12 months, > 12–24 months) (Fig. 1) [10]. Short-
term YLDs were calculated by multiplying the disabil-
ity weights by the corresponding duration over which
the disability weight applied and incidence. For ex-
ample, the 0–1 month disability weight was multiplied
by 1/12 and by the incidence of the corresponding
group; the > 1–6 month disability weight by 5/12 and
by the incidence of the corresponding group.
For the long-term (i.e. after 24 months) YLD calcu-
lations it was assumed that part of the burn popula-
tion experiences lifelong consequences, and that the
proportions of patients that experience these lifelong
consequences vary for the different homogenous burn
categories. To calculate long term YLDs the grouped
incidence data by category were combined with the
relevant disability weights and the remaining life ex-
pectancy minus 2 years [10]. Minus two years corre-
sponds to the time period of the short-term disability.
The remaining life expectancy was derived from the
GBD study [42].
Short-term and long-term YLDs were summed up
to derive YLDs on homogenous group level. The
YLDs from the different groups were again summed
to derive the overall YLDs of burns for each of the
three different countries. YLD per patient as well as
the impact of YLDs on a country population level
(i.e. YLDs divided by number of people registered in
each of the three countries) were compared among
the three different countries. Country population data
was derived from the Australian Bureau of Statistics,
Stats New Zealand and the Central Bureau of Statis-
tics Netherlands [43–45].
Data analyses
Demographics and disability weights from the com-
bined dataset were presented and compared among
the two different datasets. Mann Whitney U tests
were used for comparison of continuous variables and
chi-square tests for categorical variables. IBM SPSS
Statistics 23 was used to perform analyses and
calculations.
Fig. 1 Methodology to derive years lived with disability adapted from INTEGRIS method from Haagsma et al. [10]. 1Disabilty weights and life
expectancies are adjusted for age and sex [8]. TBSA = total body area burned
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Results
Patients
The combined dataset included 3401 patients. Of
these, 1649 originated from the European dataset and
1752 from the Western Australia dataset (Table 2).
The patients in the combined dataset had a mean age
of 41.1 years (SD 15.5) and 70.9% was male. Mean
%TBSA burned was 9.6% (SD 12.2) and patients had
a mean length of hospital stay (LOS) of 16.0 days (SD
20.7) and on average 1.3 surgeries. Most burns were
caused by flames. Patients in the European dataset
were statistically significantly older, had a higher
mean %TBSA, a longer LOS and more surgical proce-
dures (Table 2). The combined dataset included 7159
EQ-5D-3 L outcomes: 3708 outcomes were available
from the European dataset and 3451 from the West-
ern Australia dataset.
Disability weights
The calculated disability weights are presented in
Table 3. Within the subgroup < 5% TBSA burned,
disability weights ranged from 0.173 (0–1 month post-
burn) to 0.046 (long-term; > 24 months post-burn) in
the total sample. For the subgroups 5–20% TBSA





Western Australian (WA) sample
(n = 1752)
Difference between EU and
WA sample
Gender
Male, n(%) 2412 (70.9%) 1192 (72.3%) 1220 (69.6%) p = 0.089
Age
Mean (SD) 41.1 (15.5) 42.0 (14.6) 40.3 (16.3) p < 0.001
Range 18–90 years 18–90 years 18–89 years
%TBSA burned
Mean (SD) 9.6 (12.2) 13.5 (13.7) 5.9 (9.1) p < 0.001
Range 0–90% 0–90% 0–75%
%TBSA burned
0- < 5% 1587 (46.7%) 429 (26.0%) 1158 (66.1%)
5–20% 1364 (40.1%) 882 (53.5%) 482 (27.5%)
> 20% 450 (13.2%) 338 (20.5%) 112 (6.4%)
Length of hospital stay
Mean (SD) 16.0 (20.7) 23.1 (24.8) 9.1 (12.4) p < 0.001
Range 0–246 days 0–246 days 0–130 days
Nr of surgeries
Mean (SD) 1.3 (2.1) 1.5 (2.7) 1.1 (1.2) p = 0.013
Range 0–35 surgeries 0–35 surgeries 0–12 surgeries
Nr surgery, n(%)
0 720 (21.2%) 487 (29.5%) 233 (13.3%)
1 1682 (49.5%) 608 (36.9%) 1074 (61.3%)
> 1 569 (16.7%) 369 (22.4%) 200 (11.4%)
Unknown 430 (12.6%) 185 (11.2%) 245 (14.0%)
Etiology (%) p < 0.001
Scald 784 (23.1%) 277 (16.8%) 507 (28.9%)
Contact 282 (8.3%) 52 (3.2%) 230 (13.1%)
Flame 1444 (42.5%) 753 (45.7%) 691 (39.4%)
Chemical 155 (4.6%) 59 (3.6%) 96 (5.5%)
Electrical 82 (2.4%) 56 (3.4%) 26 (1.5%)
Other 129 (3.8%) 36 (2.2%) 94 (5.4%)
Unknown 525 (15.4%) 416 (25.2%) 109 (6.2%)
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burned and > 20% TBSA burned, these ranges were
0.099–0.264 and 0.122–0.497, respectively. In general,
the highest disability weights represent the recovery
phase most acutely after burns, with each subsequent
recovery phase having a diminishing disability weight.
The only exception was the disability weight for the
subgroup < 5%TBSA burned for the recovery phase >
12–24 months; this disability weight was slightly
higher than the disability weights for the earlier re-
covery phases (Table 3).
The disability weights based on the European data
and Western Australia data separately are also pre-
sented in Table 3. Disability weights up to 12 months
post-burn were significantly higher when based on
the European data compared to the Western Australia
data. In the following recovery phase (> 12–24
months), disability weights based on the Western
Australia data tended to be higher, though the differ-
ence is not significant.
Non-fatal burden of disease of burns
The adapted INTEGRIS-burns methodology was ap-
plied to estimate the non-fatal burden of disease of
burns for Australia, New Zealand and the
Netherlands. Table 4 presents the estimated YLDs for
both the subgroups and the total burn population for
these countries for 2017. The mean burden of burns
per case in Australia, New Zealand and the
Netherlands in 2017 were 1.00, 1.20 and 1.04, re-
spectively. For the different subgroups, the YLD per
case ranged from 0.65 for the < 5%TBSA burned
group for Australia and the Netherlands, to 2.59 for
the > 20% TBSA group for Australia.
The YLDs per case over time in the three countries
seem to slightly decrease over time between 2010 and
2017 (Fig. 2). Highest values in the YLDs per case were
seen for New Zealand. YLDs per case ranged between
1.10 in 2010 and 1.00 in 2017 for Australia; between
1.36 in 2010 and 1.20 in 2017 for New Zealand; and
between 1.10 in 2010 and 1.04 in 2017 for the
Netherlands.
The burden of disease of burns for the three coun-
tries in total for 2017 is also presented in Table 4.
The YLDs for the total population per 100,000 per-
sons was 280.9 for Australia, 279.2 for New Zealand
and 133.3 for the Netherlands. Over time, YLDs for
the total population seem to slightly increase in the
three countries (Fig. 3). The YLDs for the total popu-
lation ranged from 210.1 in 2010 to 280.9 in 2017 for
Australia, from 192.2 in 2010 to 279.2 in 2017 for














< 5% TBSA burned
0–1 months 0.173 (0.152 to 0.195) 0.298 (0.235 to 0.362) 0.141 (0.120 to 0.161) < 0.001
> 1–6 months 0.098 (0.090 to 0.106) 0.118 (0.098 to 0.139) 0.094 (0.085 to 0.103) 0.032
> 6–12months 0.082 (0.067 to 0.097) 0.110 (0.080 to 0.141) 0.067 (0.051 to 0.084) 0.007
> 12–24 months 0.102 (0.080 to 0.123) 0.099 (0.073 to 0.126) 0.106 (0.067 to 0.144) 0.791
> 24 months 0.046 (0.026 to 0.067) 0.046 (0.026 to 0.067) NA
5–20% TBSA burned
0–1 months 0.264 (0.238 to 0.289) 0.325 (0.286 to 0.363) 0.193 (0.163 to 0.224) < 0.001
> 1–6 months 0.139 (0.128 to 0.150) 0.160 (0.144 to 0.176) 0.113 (0.098 to 0.129) < 0.001
> 6–12months 0.118 (0.104 to 0.133) 0.134 (0.116 to 0.152) 0.085 (0.065 to 0.106) 0.001
> 12–24 months 0.108 (0.092 to 0.124) 0.106 (0.089 to 0.123) 0.119 (0.071 to 0.167) 0.593
> 24 months 0.099 (0.077 to 0.122) 0.099 (0.077 to 0.122) NA
> 20% TBSA burned
0–1 months 0.497 (0.438 to 0.557) 0.579 (0.515 to 0.643) 0.224 (0.142 to 0.307) < 0.001
> 1–6 months 0.262 (0.235 to 0.290) 0.291 (0.254 to 0.328) 0.214 (0.172 to 0.256) 0.009
> 6–12months 0.231 (0.198 to 0.263) 0.250 (0.211 to 0.288) 0.172 (0.110 to 0.233) 0.043
> 12–24 months 0.163 (0.134 to 0.191) 0.154 (0.126 to 0.182) 0.221 (0.102 to 0.340) 0.119
> 24 months 0.122 (0.092 to 0.152) 0.122 (0.092 to 0.152) NA
1056; 3238; 1355; 1001; and 509 outcomes were used to calculate the disability weights for 0–1month, > 1–6 months, > 6–12 months, > 12–24 months, and > 24
months, respectively. Values printed in bold are statistically significant
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Table 4 Estimates of the non-fatal burden of disease expressed as years lived with disability (YLD) for the different homogenous
groups of burn patients for Australia, New Zealand and the Netherlands in 2017
2017 Australia New Zealand The Netherlands
< 5% TBSA
Incidence 1849 244 445
YLD 1205.7 166.5 288.2
YLD per case 0.65 0.68 0.65
YLD total population per 100,000 122.5 91.4 48.3
5–20% TBSA
Incidence 839 143 259
YLD 1217.0 233.8 402.0
YLD per case 1.45 1.63 1.55
YLD total population per 100,000 119.6 132.6 75.7
> 20% TBSA
Incidence 162 48 40
YLD 419.2 122.0 80.4
YLD per case 2.59 2.54 2.01
YLD total population per 100,000 38.8 55.2 9.3
Total
Incidence 2850 435 744
YLD 2841.9 522.2 770.6
YLD per case 1.00 1.20 1.04
YLD total population per 100,000 280.9 279.2 133.3
Fig. 2 Estimates of the non-fatal burden of disease expressed as years lived with disability (YLD) per case for Australia, New Zealand and the
Netherlands in 2010 to 2017
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New Zealand, and from 114.5 in 2010 to 133.3 in
2017 for the Netherlands.
Discussion
The burden of disease is an important resource in
public health and there was an urgent need to adapt
a refined method to estimate of the burden of disease
for burn injuries. Three homogenous groups with
respect to health consequences have been created
based on %TBSA burned. A set of 12 short-term dis-
ability weights (four for each homogenous group) and
three life-long disability weights were derived and
presented. The time point after which we consider
disabilities caused by burns as either resolved or per-
manent was assumed to be 24 months, instead of 12
months which was used in all earlier methods. We
would argue that post-burn sequelae, including scar
symptoms and mental health challenges, are fre-
quently measurable in the period beyond one year
after injury [13, 47]. The proportion of burn patients
with lifelong disabilities was defined based on explor-
ation of HRQL data and externally validated by a
group of experts. The proportions of patients with
lifelong disabilities included 20% for the patient group
≤5% TBSA burned, 25% for the group 5–20% TBSA
burned, and 39% for the group > 20% TBSA burned.
Application of the INTEGRIS-burns method showed
that the YLD per case decreased over time from 2010
to 2017 in Australia, New Zealand and the
Netherlands, whereas the YLD per 100,000 inhabitants
tends to increase, particularly due to the increasing
incidence of burns in all three countries.
Our method created groups of burn patients with
homogenous outcomes that are easy identified within
burn data. Hereby, this method is easy to apply (i.e.
only sex, age and %TBSA burned of a burn popula-
tion is needed) and usable in settings with limited re-
sources. Besides, the definition of the most severe
group (i.e. > 20%TBSA) is in line with the criteria of
the American Burn Association [38]. We have consid-
ered other variables and more specific groups, but
that makes the method more difficult to apply. An-
other disadvantage of more specific groups is the in-
fluence of a health care system or treatment strategies
on the characteristics applied. For example, there is
evidence that HRQL and disability after burns are re-
lated with length of hospital stay [13, 36, 37]. How-
ever, length of hospital stay can be influenced by the
treatment strategy (i.e. an early excision strategy vs a
conservative approach), the parameters of the catch-
ment area, therapeutic supports outside the burn
centre and other non-treatment related issues like
policies (i.e. coverage of health care costs) or logistic
issues [48, 49], which make this characteristic not an
universal applicable variable. Other methods also used
body region affected and lower airway burns to group
Fig. 3 Estimates of the non-fatal burden of disease expressed as years lived with disability (YLD) for the total population of Australia, New
Zealand and the Netherlands in 2010 to 2017. Note. Not all burn units in Australia were contributing until 2017; and not all burn units in New
Zealand were contributing until 2013 [46]
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burn patients [1, 39]. No convincing evidence exists
on either of these variables and therefore these vari-
ables were not considered [36].
Two other important differences between our method
and the existing methods is the breakdown of recovery
after burns and the use of 24months as the time point on
which disabilities caused by burns are either resolved or
permanent. According to the recovery of HRQL in burn
patients [13, 19], we derived four short-term disability
weights up to 24months for each homogenous group,
whereas other methods only provide one 12-month dis-
ability weight per group. Earlier methods used 12months
as time point to consider a disability lifelong, even though,
it is shown that 12-months is too short for the recovery of
burns and for the maturation of scars [13, 50]. That 12
months should be reconsidered for some other injuries
was also highlighted by Gabbe et al., they stated that 12
months would not be suitable for all injuries as some have
a longer recovery phase or late improvements [39, 51].
The application of different subgroups, a different
time point on which disabilities were considered life-
long, and disability weights derived for more detailed
periods in the recovery of burns, hamper comparison
of our disability weights with those from earlier stud-
ies [1, 10, 39]. However, when roughly comparing the
disability weights, the short-term disability weights
from the present study were in about the same range
as the short-term disability weights from other studies
for burns [1, 10, 39], except for the disability weights
0–1 month after burns. Long-term disability weight
from earlier studies were defined as > 12-month dis-
ability weights and ranged between 0.019 and 0.110
for burns < 20% TBSA, which were comparable to the
> 24-month disability weights from present study for
the subgroups < 5%TBSA and 5–20% TBSA. Long-
term > 12-month disability weights presented by earl-
ier studies were between 0.156 and 0.161 for burns
≥20% TBSA [1, 39], whereas the long-term 24-month
disability weight from our study for the group >
20%TBSA was somewhat lower, most probably due to
the cut-off point of 24 months instead of 12 months.
In the present study, the highest disability weights rep-
resent the recovery period most acutely after burns, with
each following time period having a reduced disability
weight. The only exception was the disability weight for
the subgroup < 5%TBSA burned for the recovery period
> 12–24months; this disability weight was slightly higher
than the disability weights for the earlier recovery pe-
riods. This exception can be induced by selective (lost
to) follow-up. The retention rate may have been higher
among patients that continue having complaints in the
European studies; and patients who perceive that there
is benefit in attending assessments and treatment for
their long-term sequelae, remain in the Western
Australia follow-up burn care service beyond one year.
On the other hand, the slightly higher disability weight
for the recovery period > 12–24months in the < 5%
TBSA group may also be a true consequence of burns.
Earlier studies showed that some domains of HRQL
worsen in the longer-term, as well as body image and
social participation [13, 52].
Through the use of 24 months as cut-off point for
lifelong disability, we also had to investigate the pro-
portion of patients that were considered having life-
long disabilities in each group. Proportions were
determined based on data exploration and these were
validated by both clinicians and patients. The only
other method that presents proportions of patients
with lifelong consequences is the GBD study [1]. This
study presents a range of probability of long-term dis-
ability outcome [53] for two subgroups at 12 months,
with an average of 50% of the patients < 20% TBSA
and 22% of the patients ≥20%TBSA with long-term
disability outcomes. This seems to be contradictory to
all literature and our results that more severe burns
(higher %TBSA) are associated with a higher risk of
long-term consequences [36].
We applied the adapted method to estimate the non-
fatal burden of disease of burns in Australia, New Zealand
and the Netherlands. Non-fatal burden of disease esti-
mates from our study are much higher compared to the
non-fatal burden of disease estimates from the GBD study.
YLDs for 2017 presented by the GBD for burns were 78,
137 and 165 per 100,000 for the Netherlands, Australia
and New Zealand respectively [16]. The YLDs estimates
based on our adapted method lie 1.7 to 2.1 times higher.
This is in line with the results presented by Haagsma et al.
for injuries in general; compared to the conventional
methods, estimates from the refined method were 3 to 8
times higher [10]. The high differences in non-fatal bur-
den of disease estimates for the three countries are par-
ticularly induced by on the one hand the incidence rates,
with the highest incidence rates for Australia. On the
other hand, the proportion of patients with major burns
(> 20%TBSA burned) in each of the populations plays a
role; New Zealand had the highest proportion of patients
with major burns per capita which is reflected in the YLDs
per case and subsequently the total YLD estimate.
Strengths and limitations
This study has a number of strengths and limitations.
Strengths include the large combined dataset and the de-
tailed approach used to adapt the refined methodology.
We combined both study related and systematically re-
corded outcome data to compose a large and representa-
tive dataset, including outcomes from six countries and
over 3000 burns patients, to derive the disability weights.
This gave us the opportunity to study groups with
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arguably more homogenous outcomes, to derive disability
weights for five different time periods during the recovery
of burns for each group, and to study the proportion of
patients in each group that has permanent disability. A
limitation is the transformation of HRQL data to derive
one dataset. We applied the algorithm of Gray et al.
[29] to transform SF-36 data to EQ-5D data which
has shown to have moderate to good ability to esti-
mate EQ-5D scores [54] and this method was used
before for the purpose of deriving disability weights
[39]. Another limitation is that incidence rates of the
different registries included different case definitions;
data from BRANZ included patients that were admit-
ted for at least 24 h to a burn centre or had surgery;
data from the Dutch Burn Repository R3 included pa-
tients admitted for at least two hours to a specialized
burn centre. And, in contrast to Australia and New
Zealand, in the Netherlands not all burn patients with
small burns are admitted to a burn centre and only
those admitted to a burn centre are included in the
incidence rate, which might have led to an underesti-
mation of the YLDs in the Netherlands. Also, due to
privacy requirements, BRANZ did not provide inci-
dence counts for sub-grouped cells between one and
five patients. Therefore, we used an incidence rate of
2 as an average for these categories. This could have
influenced the YLDs presented for Australia, and par-
ticularly New Zealand as many low numbers were
presented for the New Zealand population. Besides,
not all burn units in Australia were contributing until
2017; and not all burn units in New Zealand were
contributing until 2013 which has influenced the
trends presented [46]. Another limitation is the inclu-
sion of only immediate health consequences in the
YLD calculation. Recent studies by Duke et al.
showed that burn patients have an increased risk of
developing cardiovascular, gastrointestinal, nervous
system and infectious diseases [55–59]. These more
delayed consequences of burns should be ideally cap-
tured in our incidence-based burden of disease ap-
proach, however, no data on such consequences was
available. Future studies should incorporate both im-
mediate and delayed health consequences to estimate
the burden of disease due to burns more completely.
Another limitation is that we solely included data
from high-income countries. We have contacted sev-
eral international experts to find data from low and
middle-income countries, but we did not manage to
access data that could be used in the present study.
The use of data from only high-income services
makes it unclear whether this method can be applied
in low and middle-income countries. It is highly likely
that disability weights will be significantly different,
when considering the impact of lack of access to
health resources and reliable acute services, such as
surgery and mechanical ventilation. Earlier studies
have shown that there are differences among coun-
tries and cultures on how people perceive health
problems and on how they find that these problems
affect their daily activities [60, 61]. Future studies
should focus on whether the application of disability
weights from high-income countries is valid in low-
and middle- income countries, as the vast majority of
burn injuries occur in low- and middle-income coun-
tries [62].
Conclusion
This project established a method for more precise
estimates of the YLDs of burns, as it is the only
method adapted to the nature of burn injuries and
their recovery. Compared to previous used methods,
the INTEGRIS-burns method includes improved dis-
ability weights based on severity categorization of
burn patients; a better substantiated proportion of
patients with lifelong disability based; and, the appli-
cation of burn specific recovery timeframes. Informa-
tion derived from the adapted method can be used
as input for health decision making at both the na-
tional and international level. Differences between
YLDs of the countries studied show that it is import-
ant to use national (or perhaps regional) data to esti-
mate the burden of disease of burns.
Appendix 1









Proportion of sample with a severe problem in any of the five EQ-5D dimensions or mild problems at both the di-
mensions pain/discomfort and anxiety/depression at 24 months
20% 25% 39%
Expert opinion:
Patients (n = 13)
14% 24% 52%
Expert opinion:
Clinicians (n = 14)
19% 31% 58%
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